HIV related opportunistic infections: Still relevant after 25 years of AIDS progress

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 6, 2008, Pages 323-324

  Kovacs, Joseph ^a   Masur, Henry ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; CIDOFOVIR; CLARITHROMYCIN; CLINDAMYCIN; DAPSONE; FOSCARNET; GANCICLOVIR; PYRIMETHAMINE; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD CULTURE; CD4 LYMPHOCYTE COUNT; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE DURATION; EDITORIAL; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; MORBIDITY; MORTALITY; MYCOBACTERIUM INTRACELLULARE AVIUM; PATHOGENESIS; PNEUMOCYSTIS PNEUMONIA; QUALITY OF LIFE; TOXOPLASMA;

EID: 45849133378     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13123835     Document Type: Editorial

References (10)

1. Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, Holzman RS, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med. 1981;305:1431-8.
2. Siegal FP, López C, Hammer GS, Brown AE, Kornfeld SJ, Gold J, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med. 1981;305:1439-44.
3. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981;305:1425-31.
4. Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984;100:663-71.
5. Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989;111:223-31.
6. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons (2002). Recommendations of the US Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51:1-46.
7. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. MMWR Recomm Rep. 2004;53:1-112.
8. Panel de expertos de GESIDA y Plan Nacional sobre el Sida. Treatment of Opportunistic Infections in Adolescents and Adult Patients Infected with Human Immnunodeficiency Virus during the Era of Highly Antiretroviral Therapy. Enferm Infecc Microbiol Clin. 2008;26:356-79.
9. Téllez I, Barragán M, Franco-Paredes C, Petraro P, Nelson K, Del Río C. Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city: a persistent and deadly opportunistic infection. Am J Med Sci. 2008;335:192-7.
10. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al; Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1-17.